News Daily News FDA Approves First New PET Imaging Tracer for Cardiac Testing in Decades Todd Neale October 02, 2024
News Daily News Deprescribing Antihypertensives May Slow Cognitive Decline in Nursing Home Patients L.A. McKeown September 27, 2024
News Daily News CVD Risk Twofold Higher in Patients With Cancer: ASPREE Michael O'Riordan September 27, 2024
News Daily News Lingering Gaps in CVD Care for Women Spotlighted in British Consensus Statement Todd Neale September 26, 2024
News Daily News Medicaid Coverage Improves CV Risk in Some, Post Hoc Analysis Shows Todd Neale September 25, 2024
News Daily News High Levels of Metals, Particularly Cadmium, Linked to Subclinical CVD Michael O'Riordan September 23, 2024
News Daily News Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced Michael O'Riordan September 20, 2024
News Daily News Little Pre- and Postmarket Testing for Most Recalled CV Devices Michael O'Riordan September 16, 2024
News Daily News Liraglutide Helps Shed Weight in Young Children With Obesity Todd Neale September 13, 2024
News Daily News Tricuspid TEER Continues to Offer Benefits Through 3 Years: TRILUMINATE Caitlin E. Cox September 12, 2024
News Daily News ACC/AHA Clarify How Social Determinants of Health Impact CVD Caitlin E. Cox August 28, 2024
News Daily News AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients Michael O'Riordan August 26, 2024
News Daily News Scientific Statement Reviews Current Antithrombotic Options in PAD L.A. McKeown August 26, 2024
News Daily News Study Supports Cost-effectiveness of Renal Denervation for Hypertension Todd Neale August 23, 2024
News Daily News FDA Approves Dropping Aspirin for HeartMate 3 LVAD Patients L.A. McKeown August 21, 2024
News Daily News Lp(a) Still Low Almost 1 Year After Last Olpasiran Injection: OCEAN(a)-DOSE Yael L. Maxwell August 19, 2024
News Daily News New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients L.A. McKeown August 19, 2024
News Daily News Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes Michael O'Riordan August 19, 2024